One Day MD

While vitamins C and D have garnered much attention in the fight against COVID-19, B vitamins can also play an important role, according to two papers — niacin (B3) in particular. The first, " Be Well: A Potential Role for Vitamin B in COVID-19 ," was published in the February 2021 issue of the journal Maturitas. The paper is the result of a joint collaboration between researchers at the University of Oxford, United Arab Emirates University and the University of Melbourne, Australia. While no studies using B vitamins have been performed on COVID-19 patients, the researchers stress that, based on B vitamins' effects on your immune system, immune-competence and red blood cells (which help fight infection), supplementation may be a useful adjunct to other prevention and treatment strategies. As noted by the authors:5 "There is a need to highlight the importance of vitamin B because it plays a pivotal role in cell functioning, energy metabolism, and proper immune functio

The number of options for the treatment of COVID-19 has increased drastically in recent months, thus making it complicated when it comes to choosing the right combination. In general, there are 3 broad categories of medical interventions: Prevention or Prophylaxis e.g. vaccine Early out-patient treatment Hospital treatment Image credit: Cleveland Clinic All these treatments come with various technologies and jargons, thus could be overwhelming and confusing for you as a consumer. Generally, multiple treatments and strategies are used in combination to achieve the best possible outcome. In this article, we would like to cover 3 popular treatments i.e. Ivermectin, Hydroxychloroquine and Quercetin. Ivermectin and COVID-19 As of May 2021, there are more than 80 on-going trials globally on Ivermectin for treatment and prevention of COVID-19 on  covid-nma.com . Source: covid-nma.com Ivermectin is an anti-parasitic medication widely used in low- and middle-income countries to treat parasitic

As of May 2021, there are still more than 3,000  clinical trials of COVID-19  treatments or vaccines that are either ongoing or recruiting patients. New ones are being added every day. The drugs or treatments being tested range from vaccines, repurposed flu treatments to failed ebola drugs, to stem cell therapy, to malaria treatments that were first developed decades ago. We know that while a large percentage of the population only experiences mild to moderate symptoms of COVID-19 and won’t require hospitalization, others experience severe symptoms and complications, require hospitalization, or may even die.  It appears one of the differences between those who have a mild illness and severe illness is related to the body's ability to reduce the hyperimmune response that leads to a cytokine storm and the hypercoagulability (tendency for blood clots) that often accompanies it. The cytokine storm may be one possible way to explain the severe reaction of thos